Charlie Plauche is a Principal at S3 Ventures. At S3, Charlie’s responsibilities include sourcing and evaluating investments in the technology and medical device sectors, performing due diligence, and portfolio company management. Prior to S3, Charlie was with Harbert Private Equity Funds, a subsidiary of Harbert Management Corporation. At Harbert, Charlie analyzed and structured leveraged buyouts in the healthcare and manufacturing sectors and assisted with portfolio management.
He received his MBA from the McCombs School at the University of Texas in Austin and his BS in Finance from the University of Mississippi, where he was a Holmes Scholarship recipient and a Mississippi Eminent Scholar. Charlie currently serves on the board of S3’s portfolio companies Alkami Technology, Kimbia, Pristine, and Tango Health. In addition, he serves as a board observer for TVA Medical, OrthoAccel Technologies, and Favor Delivery.